# Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048

> **NCT04319718** · PHASE1 · COMPLETED · sponsor: **Hillier, Sharon, PhD** · enrollment: 37 (actual)

## Conditions studied

- Pharmacokinetics
- Safety

## Interventions

- **COMBINATION_PRODUCT:** MK-2048 High Eudragit Vaginal Film
- **COMBINATION_PRODUCT:** MK-2048 Low Eudragit Vaginal Film

## Key facts

- **NCT ID:** NCT04319718
- **Lead sponsor:** Hillier, Sharon, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-19
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-10-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2023-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04319718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04319718, "Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04319718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*